Last reviewed: June 22, 2026
Last updated: June 22, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Wegovy (semaglutide) has become one of the most sought-after weight loss medications, with clinical trials showing patients lose an average of 15% of body weight over 68 weeks. However, traditional Wegovy approval can be complicated by insurance requirements, supply shortages, and strict eligibility criteria. PlexusDx provides a streamlined path to semaglutide therapy through licensed 503A compounding pharmacies, making this proven GLP-1 receptor agonist accessible nationwide without insurance requirements.
What Are the Official Approval Requirements for Wegovy?
Wegovy approval through traditional channels requires meeting specific FDA-established criteria. You must have a body mass index (BMI) of 30 kg/m² or higher, or a BMI of 27 kg/m² or higher combined with at least one weight-related condition such as type 2 diabetes, high blood pressure, or sleep apnea. Your healthcare provider must document that you have attempted lifestyle modifications without sufficient weight loss before prescribing Wegovy.
Insurance coverage adds another layer of complexity to the approval process. Many insurance plans classify Wegovy as a cosmetic weight loss drug rather than a medical necessity, leading to denials or high out-of-pocket costs. Prior authorization requirements can delay treatment by weeks or months, during which time patients may lose motivation or experience worsening metabolic health. The FDA-approved Wegovy is also frequently on backorder, leaving many patients without access to treatment even after approval.
Why Compounded Semaglutide Offers a Faster Alternative Path
Compounded semaglutide delivers the same active pharmaceutical ingredient as Wegovy but comes from licensed 503A compounding pharmacies rather than manufacturers. This distinction means PlexusDx can serve all 50 states immediately, without insurance gatekeeping or supply chain delays. The medication undergoes the same quality controls and pharmaceutical standards as brand-name versions, ensuring safety and efficacy for patients who meet clinical criteria.
PlexusDx streamlines the approval process by working directly with patients and licensed practitioners to assess suitability based on your health history, current weight, and metabolic goals. You avoid the insurance approval waiting period entirely, and treatment can often begin within days rather than weeks. Compounded semaglutide injections start at just $149 per month, making it significantly more affordable than many insurance copays for Wegovy.
How PlexusDx Determines Your Eligibility for Semaglutide Therapy
PlexusDx evaluates candidates for compounded semaglutide using clinical guidelines that mirror FDA standards while removing insurance barriers. During your initial consultation, you'll be asked about your BMI, medical history, previous weight loss attempts, and any weight-related conditions. Your practitioner will review current medications and potential contraindications to ensure semaglutide is appropriate for your individual health profile.
Unlike traditional approval processes that rely on insurance company decisions, PlexusDx places clinical judgment in the hands of licensed healthcare providers who understand GLP-1 therapy. You may also qualify for the Precision Peptide Genetic Test ($99 add-on after your first month), which maps 14 metabolic pathways and identifies genetic variants that predict your individual response to semaglutide. This personalized approach helps optimize your treatment outcome from the very beginning.
Getting Started With Compounded Semaglutide at PlexusDx
Starting compounded semaglutide through PlexusDx requires minimal steps compared to traditional insurance-based approval. First, you'll complete a brief health assessment and connect with a licensed practitioner who reviews your eligibility. If you're a suitable candidate, your prescription is sent to a licensed 503A compounding pharmacy, and your first shipment typically arrives within 7–10 business days.
Your dose may need to go up over time as your body adjusts to treatment, but your monthly price remains flat at $149—no hidden costs or surprise copays. PlexusDx accepts HSA and FSA payments, and no membership fee is required. You maintain direct communication with your care team throughout your weight loss journey, with ongoing support to monitor your progress and adjust your treatment plan as needed.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Can I get approved for Wegovy if I don't meet the BMI requirement?
Traditional Wegovy approval is strict about BMI thresholds, but PlexusDx evaluates semaglutide eligibility more holistically. If you have significant weight-related health concerns, metabolic risk factors, or unsuccessful prior weight loss attempts, a licensed practitioner may determine that compounded semaglutide is medically appropriate for you even if your BMI is slightly below 30.
How much weight can I expect to lose with compounded semaglutide?
Clinical trials show that semaglutide users lose an average of 10–15% of their body weight over 68 weeks when combined with lifestyle modifications. Individual results vary based on genetics, adherence to the program, and diet changes. PlexusDx offers the Precision Peptide Genetic Test to identify your genetic predispositions, which helps predict your likely response and personalize your treatment plan.
Is compounded semaglutide as safe as brand-name Wegovy?
Compounded semaglutide from PlexusDx comes from licensed 503A compounding pharmacies that follow strict pharmaceutical standards identical to those for FDA-approved medications. The active ingredient is identical to Wegovy; the only difference is the source. Both forms carry the same potential side effects (nausea, constipation, headache) and require the same medical oversight and monitoring.
Why is PlexusDx semaglutide so affordable compared to Wegovy?
PlexusDx pricing starts at $149 per month because compounded medications bypass manufacturer markups and insurance middleman costs. You pay directly for the medication without copays, deductibles, or prior authorization fees. This direct-to-patient model makes GLP-1 therapy affordable for everyone, and your price never increases as your dose increases.
What does the Precision Peptide Genetic Test tell me about my semaglutide response?
The Precision Peptide Genetic Test ($99 after your first month) analyzes key variants in genes like GLP1R, GIPR, FTO, and MC4R that influence how your body metabolizes and responds to semaglutide. By mapping 14 metabolic pathways and 150+ genetic insights, this test helps predict your individual weight loss potential and guides dose adjustments for maximum efficacy.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Navigating Weight Loss and Bone Health: Does Ozempic Eat Your Bones?
Understanding Why Ozempic Makes You Lose Weight